Organogenesis Holdings Inc. (ORGO) 8-K Current Report: February 23, 2026
Filed: February 23, 2026
Health Care
Pharmaceutical PreparationsOrganogenesis Holdings Inc. (ORGO) 8-K current report filed with SEC EDGAR on February 23, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 5.02: Departure/Election of Directors or Officers
Organogenesis Holdings Inc. 8-K Feb 23, 2026 Event Analysis
Item 5.02 · Departure/Election of Directors or Officers
- • Patrick McGuire, 40, appointed Chief Accounting Officer effective Feb 18, 2026; promoted from VP Corporate Controller (held since Sept 2023)
- • Base salary set at $345,000; no other compensation changes
- • McGuire brings 13+ years PwC experience in pharma/life sciences/medical device sector
- • David Francisco transitions out of principal accounting officer role but retains CFO and principal financial officer titles — no leadership vacuum at CFO level
Other Organogenesis Holdings Inc. 8-K Filings
Get deeper insights on Organogenesis Holdings Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.